SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001682852-24-000060
Filing Date
2024-11-07
Accepted
2024-11-07 16:03:09
Documents
88
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrna-20240930.htm   iXBRL 10-Q 1459633
2 EX-10.1 exhibit1019302024.htm EX-10.1 45280
3 EX-31.1 exhibit3119302024.htm EX-31.1 9149
4 EX-31.2 exhibit3129302024.htm EX-31.2 9094
5 EX-32.1 exhibit3219302024.htm EX-32.1 8233
11 mrna-20240930_g1.jpg GRAPHIC 63925
12 mrna-20240930_g2.jpg GRAPHIC 360618
  Complete submission text file 0001682852-24-000060.txt   9380308

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrna-20240930.xsd EX-101.SCH 54303
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrna-20240930_cal.xml EX-101.CAL 112123
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrna-20240930_def.xml EX-101.DEF 198829
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrna-20240930_lab.xml EX-101.LAB 571538
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrna-20240930_pre.xml EX-101.PRE 417482
90 EXTRACTED XBRL INSTANCE DOCUMENT mrna-20240930_htm.xml XML 1552698
Mailing Address 325 BINNEY STREET CAMBRIDGE MA 02142
Business Address 325 BINNEY STREET CAMBRIDGE MA 02142 6177146500
Moderna, Inc. (Filer) CIK: 0001682852 (see all company filings)

IRS No.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38753 | Film No.: 241435433
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)